Table: Kobayashi Pharmaceutical -Q1 group results

Kobayashi Pharmaceutical

10/05/2023 07:00

May 10 (Reuters)- 
             Kobayashi Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Mar 31, 2023        Mar 31, 2022     Dec 31, 2023 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             33.47               32.65           172.00    
                 (+2.5 pct)          (+7.9 pct)       (+3.5 pct)  
  Operating          5.06                4.85            25.50    
                 (+4.5 pct)          (+3.3 pct)       (-4.4 pct)  
  Recurring          5.17                5.10            26.50    
                 (+1.3 pct)          (-1.8 pct)       (-6.3 pct)  
  Net                3.61                3.47            20.20    
                 (+3.9 pct)          (-4.3 pct)       (+0.9 pct)  
  EPS             47.43 yen           44.87 yen       265.74 yen  
  Ann Div                             90.00 yen        92.00 yen  
  -Q2 div                             38.00 yen        39.00 yen  
  -Q4 div                             52.00 yen        53.00 yen  
  
  NOTE - Kobayashi Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4967.T